USPTO
uspto.report › patent › grant › 9587003
Modified polynucleotides for the production of oncology-related proteins and peptides Patent Grant Bancel , et al. March 7, 2 [Moderna Therapeutics, Inc.]
U.S. Patent Number 09587003 for Modified polynucleotides for the production of oncology-related proteins and peptides
RPX Insight
insight.rpxcorp.com › patent › US9587003B2
US 9,587,003 B2 - Modified polynucleotides for the production ...
US 9,587,003 B2 · Filed: 02/04/2016 · Issued: 03/07/2017 · Est. Priority Date: 04/02/2012 · Status: Active Grant · × · Create Patent Alert · Alert · Pin · 0 · Associated Cases · 0 · Associated Defendants · 0 · Product Citations · 0 · Petitions ·
Unified Patents
portal.unifiedpatents.com › patents › patent › US-9587003-B2
US-9587003-B2 - Modified Polynucleotides for the ...
To use Unified Patents Portal, please enable JavaScript
Google Patents
patents.google.com › patent › US9587003B2 › en
US9587003B2 - Modified polynucleotides for the production of oncology-related proteins and peptides - Google Patents
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of oncology-related polynucleotides, oncology-related primary transcripts and oncology-related mmRNA molecules.
FPO
freepatentsonline.com › 9587003.html
Modified polynucleotides for the production of oncology-related proteins and peptides - Moderna Therapeutics, Inc.
International Search Report and Written Opinion from International Application Serial No. PCT/US13/030067 dated Dec. 20, 2013, Inventor(s) Stephane Bancel, et al., Title: Modified Polynucleotides for the Production of Nuclear Proteins, Filing Date: Mar. 9, 2013.
Dimensions
app.dimensions.ai › details › patent › US-9587003-B2
Modified polynucleotides for the production of oncology-related proteins and peptides - Dimensions
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of oncology-related polynucleotides, oncology-related primary transcripts and oncology-related mmRNA molecules.
Google APIs
patentimages.storage.googleapis.com › 01 › 6e › 60 › 8951ab8f4118b5 › US9587003.pdf pdf
Googleapis
We cannot provide a description for this page right now
Health Feedback
healthfeedback.org › home › claim-reviews › short identical gene sequence in sars-cov-2 and a gene sequence patented by moderna can be found in other organisms; not evidence that virus was engineered
Short identical gene sequence in SARS-CoV-2 and a gene sequence patented by Moderna can be found in other organisms; not evidence that virus was engineered - Health Feedback
August 22, 2024 - Moderna’s patent US 9587003, which was filed in 2017, can be found here, and the complete sequence of the modified gene, given the number 11652, is shown here on GenBank, a database of nucleic acid sequences maintained by the U.S. National Center for Biotechnology Information (NCBI).
The Lens
lens.org › lens › patent › 193-638-595-303-053 › frontpage
US 9587003 B2 - Modified polynucleotides for the production of oncology-related proteins and peptides - The Lens - Patent and Scholarly Search and Analysis
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of oncology-related polynucleotides, oncology-related primary transcripts and oncology-related mmRNA molecules.
SWFI
swfinstitute.org › news › 91484 › scientists-discover-dna-chunk-in-covid-that-matches-moderna-patented-sequence-from-before-pandemic
Largest And Global Sovereign Wealth Fund Institute | SWFI
SWFI is an investor research platform offering family offices, private equity firms, banks, and institutional investors actionable news, insights, and data.
Moderna
modernatx.com › sites › default › files › US10702600.pdf pdf
Modernatx
Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.
Summit Racing
summitracing.com › parts › rnb-587-003 › all › make › honda › model › civic
Dorman 587-003 Dorman Hybrid Battery Packs | Summit Racing
Dorman Hybrid Battery Packs
Battery, Hybrid Drive Battery Pack, Honda, Civic Hybrid, 2003-05, Each
Price $2,745.95
Rio Times
riotimesonline.com › home › moderna patented component of coronavirus three years before pandemic
Moderna patented component of Coronavirus three years before pandemic ...
February 28, 2022 - Scientists have discovered genetic material in the spike protein of SARS-CoV-2, which was patented by vaccine manufacturer Moderna
Google Patents
patents.google.com › patent › US9669008B1 › en
US9669008B1 - Enalapril formulations - Google Patents
Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
Reuters
reuters.com › business › healthcare-pharmaceuticals › moderna-covid-19-vaccine-patent-dispute-headed-court-us-nih-head-says-2021-11-10
Moderna COVID-19 vaccine patent dispute headed to court, U.S. NIH head says | Reuters
November 11, 2021 - U.S. National Institutes of Health scientists played "a major role" in developing Moderna Inc's COVID-19 vaccine and the agency intends to defend its claim as co-owner of patents on the shot, NIH Director Dr.
Lexor Miami
lexormiami.com › home › saint laurent sl 587/k-003 53 sunglass unisex recycled
Saint Laurent SL 587/K-003 53 Sunglass UNISEX RECYCLED – Lexor Miami
Saint Laurent SL 587/K-003 53 Sunglass UNISEX RECYCLED
Saint Laurent SL 587/K-003 53 Sunglass UNISEX RECYCLED
UPC: 889652421001
Founded in 1961, Yves Saint Laurent was the first couture house to introduce the concept of luxury prêt-à-porter in a 1966 collection called « Rive Gauche », synonymous with youth and freedom. This shift represented a first critical step in the modernization of fashion and revolutionized the socio-cultural landscape.In 1999, the luxury goods division of the PPR Group acquired Yves Saint Laurent and, under the creative direction of Anthony Vaccarello since April 2016, continues to position the House at the summit of the
Price $305.00
GovInfo
govinfo.gov › content › pkg › CFR-2023-title5-vol1 › xml › CFR-2023-title5-vol1-part581-appA.xml
List of Agents Designated To Accept Legal Process
Routt—Forest Supervisor, 29587 W. US 40, Suite 20, Steamboat Springs, CO 80487-9550, (303) 879-1722
SEC.gov
sec.gov › Archives › edgar › data › 904333 › 000095014901000010 › 0000950149-01-000010.txt
Sec
This includes $85,378 in transactions with other SchwabFunds(R). b Market value of securities loaned: $158,163. c These derive from investments and futures. As of the report date, the fund had twelve open Russell 2000 futures contracts due to expire on December 15, 2000, with a contract value of $3,003 and unrealized losses of $257.
Unified Patents
portal.unifiedpatents.com › patents › patent › 11040023
Unified Patents - Analytics Portal
To use Unified Patents Portal, please enable JavaScript